Earnings · China A-shares
Aurisco Pharmaceutical Co. Ltd. Class A (605116) earnings
Aurisco Pharmaceutical Co. Ltd. Class A published its Q3 report on 2026-10-30: net profit -37.53% year on year, -37.16% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +0.99% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -37.53%
- Excl. one-offs YoY
- -37.16%
- Net profit QoQ
- -34.49%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -4.38% | — |
| 3 days | +0.99% | — |
| 7 days | +0.11% | — |
| 14 days | -10.57% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 2 of 7 reports (average -2.88%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | ¥220.86M | -37.53% | -37.16% | -1.87% | 0.54 | 8.11% | +0.99% | — | — |
| 2026 interim report | 2026-08-29 | ¥158.74M | -32.42% | -32.43% | +0.78% | 0.39 | 5.80% | -1.92% | -9.32% | +0.01% |
| 2026 Q1 report | 2026-04-24 | ¥63.93M | -46.47% | -48.16% | -3.17% | 0.16 | 2.38% | -11.55% | -29.81% | -30.23% |
| 2025 annual report | 2026-04-17 | ¥449.21M | +26.61% | +24.43% | +15.03% | 1.12 | 22.05% | -6.51% | -30.75% | -34.73% |
| 2025 Q3 report | 2025-10-31 | ¥353.54M | +24.58% | +21.46% | +13.67% | 0.87 | 14.37% | +2.94% | -2.94% | +1.74% |
| 2025 interim report | 2025-08-29 | ¥234.90M | +24.55% | +20.94% | +12.50% | 0.58 | 9.59% | -1.63% | -5.28% | -6.55% |
| 2025 Q1 report | 2025-04-26 | ¥119.42M | +45.30% | +37.51% | +19.78% | 0.30 | 4.97% | -2.49% | +4.74% | +1.50% |
| 2024 annual report | 2025-04-26 | ¥354.79M | +22.59% | +34.25% | +16.89% | 0.89 | 17.35% | -2.49% | +4.74% | +1.50% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.